Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Revenue (2016 - 2025)

Historic Revenue for Dare Bioscience (DARE) over the last 9 years, with Q3 2025 value amounting to $2262.0.

  • Dare Bioscience's Revenue fell 9457.44% to $2262.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$57130.0, marking a year-over-year decrease of 10303.67%. This contributed to the annual value of $9784.0 for FY2024, which is 9965.16% down from last year.
  • According to the latest figures from Q3 2025, Dare Bioscience's Revenue is $2262.0, which was down 9457.44% from -$21172.0 recorded in Q2 2025.
  • Over the past 5 years, Dare Bioscience's Revenue peaked at $10.0 million during Q2 2022, and registered a low of -$63647.0 during Q4 2024.
  • Moreover, its 4-year median value for Revenue was $23932.5 (2024), whereas its average is $1.3 million.
  • The largest annual percentage gain for Dare Bioscience's Revenue in the last 5 years was 17334.98% (2025), contrasted with its biggest fall of 19435.78% (2025).
  • Quarter analysis of 4 years shows Dare Bioscience's Revenue stood at $10.0 million in 2022, then tumbled by 81.92% to $1.8 million in 2023, then crashed by 103.52% to -$63647.0 in 2024, then skyrocketed by 103.55% to $2262.0 in 2025.
  • Its Revenue stands at $2262.0 for Q3 2025, versus -$21172.0 for Q2 2025 and $25427.0 for Q1 2025.